| 36928723 | Correction: The Role of Attachment Styles on Quality of Life and Distress Among Early-Stage Female Breast Cancer Patients: A Systematic Review. | J Clin Psychol Med Settings | 2023 |
| 37643779 | Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing. | Cancer Genomics Proteomics | 2023 |
| 34949660 | Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients. | Cancer Genomics Proteomics | 2022 |
| 35610366 | Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial. | Br J Cancer | 2022 |
| 35526835 | Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer. | J Mol Diagn | 2022 |
| 34238931 | Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study. | NPJ Breast Cancer | 2021 |
| 33893081 | Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer. | Cancer Genomics Proteomics | 2021 |
| 32146094 | The challenge of avoiding over- and under-treatment in older women with ductal cancer in situ: A scoping review of existing knowledge gaps and a meta-analysis of real-world practice patterns. | J Geriatr Oncol | 2020 |
| 32075718 | Theoretical and practical knowledge curriculum for European Breast Surgeons. | Eur J Surg Oncol | 2020 |
| 31706719 | Multigene assays in early breast cancer: Insights from recent phase 3 studies. | Eur J Surg Oncol | 2020 |
| 32706636 | Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials. | J Clin Oncol | 2020 |
| 32303794 | Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density? | Cancer Immunol Immunother | 2020 |
| 31159747 | Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations. | BMC Cancer | 2019 |
| 31933581 | European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes. | Breast Care (Basel) | 2019 |
| 31933578 | Towards Harmonisation of Breast Care in Europe. | Breast Care (Basel) | 2019 |
| 29174281 | Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: AÂ comprehensive review of current data. | Eur J Surg Oncol | 2018 |
| 29917140 | Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial. | J Natl Cancer Inst | 2018 |
| 29885375 | Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial. | Eur J Cancer | 2018 |
| 30063723 | Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial. | PLoS One | 2018 |
| 30420699 | Pathway-based subnetworks enable cross-disease biomarker discovery. | Nat Commun | 2018 |
| 29310832 | Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center. | Cancer Genet | 2018 |
| 27639633 | Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information? | Eur J Surg Oncol | 2017 |
| 28441617 | The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer: When might multigene assays be of value? | Breast | 2017 |
| 28649643 | Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine. | NPJ Breast Cancer | 2017 |
| 28666187 | Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy. | Transl Oncol | 2017 |
| 28551632 | The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy. | Anticancer Res | 2017 |
| 28732650 | Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial. | Lancet Oncol | 2017 |
| 28602710 | Controversial issues in the management of older adults with early breast cancer. | J Geriatr Oncol | 2017 |
| 26970928 | Screening mammography: Usefulness beyond early detection of breast cancer. | Atherosclerosis | 2016 |
| 29894075 | Incidence of inactive allele CYP2D6*4 among Greek women suffering from hormone-sensitive breast cancer. | Eur J Gynaecol Oncol | 2016 |
| 27117158 | The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies. | Breast Cancer Res Treat | 2016 |
| 27446480 | White blood cell and platelet indices as prognostic markers in patients with invasive ductal breast carcinoma. | Oncol Lett | 2016 |
| 27369359 | Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes. | Breast Cancer Res Treat | 2016 |
| 27212697 | Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons. | Breast | 2016 |
| 26717057 | Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial. | Arch Pathol Lab Med | 2016 |
| 26681681 | Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel. | Ann Oncol | 2016 |
| 25591836 | Does patient education work in breast cancer? Final results from the global CARIATIDE study. | Future Oncol | 2015 |
| 26610383 | A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer. | Adv Ther | 2015 |
| 26284903 | Combination of Calcium Hydroxyapatite Antibiotic Carrier with Cement Spacers in Peri-Prosthetic Knee Infections. | Surg Infect (Larchmt) | 2015 |
| 25963429 | Surgery for liver metastases from breast cancer. | Future Oncol | 2015 |
| 25767734 | Inflammatory myofibroblastic tumor of the breast. | Case Rep Surg | 2015 |
| 24184673 | Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness. | Eur J Pharm Biopharm | 2014 |
| 25314051 | Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer. | Br J Cancer | 2014 |
| 25071141 | Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study. | J Clin Oncol | 2014 |
| 25026897 | Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial. | BMC Cancer | 2014 |
| 25114852 | Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen. | World J Clin Oncol | 2014 |
| 24949917 | The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes. | Anticancer Drugs | 2014 |
| 24675394 | The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study. | Breast | 2014 |
| 24475110 | A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon. | PLoS One | 2014 |
| 24158740 | When and how to operate on thoracic and lumbar spine fractures? | Eur J Orthop Surg Traumatol | 2014 |